Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Prepaid Assets (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Prepaid Assets for 16 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 38.11% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Dec 2025, down 38.11% year-over-year, with the annual reading at $3.4 million for FY2025, 38.11% down from the prior year.
  • Prepaid Assets for Q4 2025 was $3.4 million at Anika Therapeutics, down from $5.1 million in the prior quarter.
  • The five-year high for Prepaid Assets was $10.5 million in Q1 2022, with the low at $3.4 million in Q4 2025.
  • Average Prepaid Assets over 5 years is $7.4 million, with a median of $7.8 million recorded in 2023.
  • The sharpest move saw Prepaid Assets surged 70.49% in 2021, then plummeted 38.11% in 2025.
  • Over 5 years, Prepaid Assets stood at $8.3 million in 2021, then grew by 6.5% to $8.8 million in 2022, then decreased by 15.31% to $7.5 million in 2023, then fell by 26.51% to $5.5 million in 2024, then tumbled by 38.11% to $3.4 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $3.4 million, $5.1 million, and $5.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.